Replies to post #394836 on Amarin Corp Plc (AMRN)

[couldbebetter]

JRoon71, With positive BRAVE results, that would be an incentive for CVD
patients in "protected jurisdictions" to go out of their way to be prescribed
Vascepa. Of course, CVD is linked to AD, so for the reasons I mentioned
it is not a stretch to believe Vascepa would help with both indications. Maybe
BP would be more proactive (should the BRAVE study show efficacy) than
AMRN in GIA mode, to get the word out to doctors who would understand
the logic. Such a great drug that Vascepa could have been.

[rosemountbomber]

Unfortunately, what I suspect will happen is that (in the U.S.) the generics (and OTC supplement makers) will be the beneficiaries of this windfall.

With the current state of affairs here in the States, that is the most logical assumption.